Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

medical cannabis

  • Home
  •  
  • medical cannabis



  • Most Read
  • Latest Comments
  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • News

  • Melodiol reports positive results from Halucenex trials for magic mushrooms to treat PTSD
    Melodiol reports positive results from Halucenex trials for magic mushrooms to treat PTSD
    • News

  • ECS Botanics secures exclusive supply agreement with MediCann for $24 million worth of cannabis flowers
    ECS Botanics secures exclusive supply agreement with MediCann for $24 million worth of cannabis flowers
    • News

  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • News

    Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic

    Over the past several months, medical cannabis company Melodiol Global Health’s (ASX: ME1) subsidiary Health House Australia has been gearing up for the launch of its medicinal cannabis clinic.  After significant internal analysis and planning, Health House Australia expects the Health House Wellness Clinic to be operational in Q2 of CY24. The Health House Wellness

    Read More
    Public
  • ECS Botanics secures exclusive supply agreement with MediCann for $24 million worth of cannabis flowers
    • News

    ECS Botanics secures exclusive supply agreement with MediCann for $24 million worth of cannabis flowers

    B2B pharmaceutical company and medical cannabis cultivator ECS Botanics (ASX: ECS) has secured an offtake agreement to supply medical cannabis dried flowers to Perth-based medical cannabis company MediCann Health over the next five years.

    Read More
    Public
  • Little Green Pharma locks in major sales agreement with German cannabis company
    • News

    Little Green Pharma locks in major sales agreement with German cannabis company

    Australian medical cannabis company Little Green Pharma (ASX: LGP) has reached a major offtake agreement with Demecan to distribute cannabis products across Germany. With the German medical cannabis market estimated to be worth €7.7bn (A$11.2bn) by 2028, this opportunity marks a massive milestone for the Company. In July 2021, LGP acquired a world-class cultivation site

    Read More
    Public
  • Top cannabis grower enters production deal with THC Global
    • News

    Top cannabis grower enters production deal with THC Global

    In preparation for legislative changes which may soon see cannabis products purchasable over the counter without a prescription, leading medicinal cannabis product manufacturer THC Global (ASX: THC) has partnered with Cannatrek to produce white-labeled CBD products at their high-volume Southport facility in Queensland.  As a sizable grower of medicinal cannabis with a diverse range of

    Read More
    Public
  • ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading
    • News

    ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading

    Medical cannabis producer, Cann Group Limited (ASX: CAN) have announced this morning their response to yesterday’s price query from the ASX that lead to the company being placed in a trading halt soon after. The regulator probed the company to ‘please explain’ yesterday’s trading activity which saw almost a 19% increase in trading price and

    Read More
    Public
  • Medical cannabis adoption trend continuing in UK after Althea Group secures key licence
    • News

    Medical cannabis adoption trend continuing in UK after Althea Group secures key licence

    Australian-based Medical Cannabis producer and supplier, Althea Group (ASX: AGH), have announced this morning that their Bristol-based medical clinic site has secured a licence from a UK independent health and social care regulator. The news suggests that medical cannabis is becoming increasingly accepted in the UK as a treatment option for chronic health conditions.  Wholly

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.